Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ticker | Board | News | Price | Change | Chg% | Added | ||||
---|---|---|---|---|---|---|---|---|---|---|
EBZT | Everything Blockchain Inc | 0.09375 | 0.01875 | 25.00% | 04/20/2023 | |||||
My EBZT Pitch: This company uses blockchain technology to develop zero trust DBMS solutions. The company recently partnered with the Center for Internet Security (CIS) Cyber Market, a collaborative purchasing program that serves U.S. State, Local, Tribal and Territorial (SLTT) government organizations, nonprofit
|
||||||||||
IDEX | Ideanomics Inc | 0 | 0 | 0.00% | 04/20/2023 | |||||
My IDEX Pitch: This EV company generates over $100 million/year in revenue and always seems undervalued. It's subsidiaries include WAVE which is a charging plate that can be imbedded in the road and is currently used to recharge electric busses at bus stops, Solectrac, one of the first electric tractor companies,
|
||||||||||
BTZI | Bots Inc | 0.0014 | 0.0 | 0.00% | 09/05/2020 | |||||
My BTZI Pitch: Fully reporting, zero debt, & shareholder friendly holding company. Recently acquired by First Bitcoin (BITCF) and switched business plan from marijuana to blockchain and cryptocurrency software. Nice long term potential.
|
||||||||||
ARMP | Armata Pharmaceuticals, Inc. | 2.4 | 0.17 | 7.62% | 03/10/2018 | |||||
My ARMP Pitch: Developing a new method for creating antibiotics for resistant bacteria. Featured in Time magazine article Dec 25, 2017. Potential for eventually replacing all current antibiotics.
|
||||||||||
INM | InMed Pharmaceuticals Inc | 0.227 | -0.0461 | -16.88% | 11/04/2017 | |||||
My INM Pitch: MJ pharma company that has been labeled a mini GWPH. Several drugs in development: a glaucoma treatment and a drug to treat Epidermolysis Bullosa (EB). Patented Biosynthesis and Bioinformatics processes can reproduce 90+ different cannabinoids from bacteria and predict which ailments they can treat.
|